Back
Tempest Therapeutics, Inc. 10K Form
Sell
14
TPST
Tempest Therapeutics, Inc.
Last Price:
$1.58
Seasonality Move:
-13.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TPST News And Ratings
See the #1 stock for the next 7 days that we like better than TPST
TPST Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-6.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.43 |
| Price / Book: | 3.42 |
Profitability
| EPS (TTM): | -10.10290 |
|---|---|
| Net Income (TTM): | $-36.1M |
| Gross Margin: | $-266K |
| Return on Equity: | -311.64% |
| Return on Assets: | -118.88% |
Tempest Therapeutics, Inc. Earnings Forecast
Key Tempest Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 15 years have been positive in 9 years.
Tempest Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TPST |
| Website: | tempesttx.com |
Debt
| Debt-to-Equity Ratio: | 1.32 |
|---|---|
| Current Ratio: | 2.3 |
| Quick Ratio: | 2.13 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TPST Technical Analysis vs Fundamental Analysis
Sell
14
Tempest Therapeutics, Inc. (TPST)
is a Sell
Is Tempest Therapeutics, Inc. a Buy or a Sell?
-
Tempest Therapeutics, Inc. stock is rated a SellThe current Tempest Therapeutics, Inc. [TPST] share price is $1.59. The Score for TPST is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.